We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Turning Tumors Into Cancer Vaccine Factories

News   Apr 09, 2019 | Original story from Mount Sinai Health System

 
Turning Tumors Into Cancer Vaccine Factories
 
 
Advertisement
 

RELATED ARTICLES

Plant Compound Improves Cognition and Memory in Model of Down Syndrome

News

The plant compound apigenin improved the cognitive and memory deficits usually seen in a mouse model of Down syndrome, according to a study by researchers at the National Institutes of Health and other institutions.

READ MORE

Investigational Drug Safely Slows Progression of Diabetic Kidney Disease in Clinical Trial

News

Patients with diabetic kidney disease could potentially be treated with an investigational new drug that may slow the progress of their illness without harmful adverse effects to their hearts, according to the results of a recent global clinical trial.

READ MORE

Inhibitor of Cancer-Causing KRAS Gene Mutation Shrinks Tumors and is Well-Tolerated

News

A novel agent that targets a mutated form of the KRAS gene shrank tumors in most patients in a clinical trial with manageable side effects, researchers reported today.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE